Access EIS investments for August 2024

Syndicate Room

4 September 2024•2 min read

In August we added one new startup to the Access EIS portfolio, investing alongside super angels in each case (for more on our super angels, and our co-investment model, see our [dedicated page](/invest/angel-investors). You can read about our new portfolio company below. If you're interested in making an investment and building your own portfolio of promising startups, [start here](/how-to-invest). ### Lighthearted AI Lighthearted AI is a heart disease diagnostics company that aims to make diagnostics quick, cheap and simple. Its precision cardiology platform revolutionises heart disease diagnosis by using laser-based technology and advanced AI. This innovative approach acquires biomarkers from a distance, enabling quick and accurate diagnostic reports without expert intervention, making the process more accessible and efficient. Its mission is to prevent 10 million deaths by 2030 through the use of a novel non-contact device that detects heart conditions quickly and accurately. Text in white saying Lighthearted on a dark blue background

Text in white saying Lighthearted on a dark blue background

Our angel partner in the round has an IRR of 49% and their previous investments include Aztec, Bloom & Wild, Curve. **Total Round:** £750,000. **Stage** Pre-revenue. [Visit website](https://www.lighthearted.ai/)

What is Access EIS?

Read our fund brochure for everything you need to know about Access, from the specifics of our innovative co-investment model to our fees, and how to invest.

Risk warning: Please click here to read the full risk warning.

Investing in early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Tax relief depends on an individual’s circumstances and may change in the future. In addition, the availability of tax relief depends on the company invested in maintaining its qualifying status. Past performance is not a reliable indicator of future performance. You should not rely on any past performance as a guarantee of future investment performance.

This page has been approved as a financial promotion by Syndicate Room Ltd, which is authorised and regulated by the Financial Conduct Authority (No. 613021).

We use cookies to improve our service. By continuing to use this site you are agreeing to their use. Find out more.